http://grants.nih.gov/grants/guide/notice-files/NOT-OD-09-003.html At 11:44 AM 10/8/2008, you wrote: >I'm trying to locate the link on the NIH site in order to include it in on >our website and NOT-OD-09-003 is not producing any results when I search for >it. Does anyone have the direct link to the notice they could share with >me? >Thank you! > >-----Original Message----- >From: Research Administration List [mailto:xxxxxx@hrinet.org] On Behalf Of >Aull, Robert Matthew >Sent: Wednesday, October 08, 2008 10:42 AM >To: xxxxxx@hrinet.org >Subject: [RESADM-L] New NIH Policy on Resubmission (Amended) Applications > >NIH has revised its renewal policy from three strikes to "two strikes and >you're out." > >Currently funded projects will be grandfathered to allow three attempts for >continued funding but they won't accept any -A2 applications after January >7, 2011. > >1st try: R01AA012345-06 >2nd try: R01AA012345-06A1 >3rd try: R01AA012345-06A2 (NLT 7 Jan 11) > >Robert Aull >Indiana University > > >New NIH Policy on Resubmission (Amended) Applications >---------------------------------------------------------------------------- > >Notice Number: NOT-OD-09-003 > >Key Dates >Release Date: October 8, 2008 > >Issued by >National Institutes of Health (NIH), (http://www.nih.gov) > >Purpose > >NIH announces a change in the existing policy on resubmission (amended) >applications (see http://grants.nih.gov/grants/policy/amendedapps.htm). >Beginning with original new applications (i.e., never submitted) and >competing renewal applications submitted for the January 25, 2009 due dates >and beyond, the NIH will accept only a single amendment to the original >application. Failure to receive funding after two submissions (i.e., the >original and the single amendment) will mean that the applicant should >substantially re-design the project rather than simply change the >application in response to previous reviews. It is expected that this >policy will lead to funding high quality applications earlier, with fewer >resubmissions. > >Background > >Following the release of the Peer Review Report that was drafted with >extensive consultation with the external community, Dr. Zerhouni, NIH >Director, established a Peer Review Oversight Committee (PROC) to finalize >the recommendations and begin immediate implementation of those >recommendations. Of particular concern was the marked reduction in the >number of awards made in response to original applications. An increasing >number of projects were funded only after one or more resubmissions. In >periods of constricted funding, a greater number of projects require >resubmission, and review committees are more likely to show greater >preference for amended applications. These trends have increased the time >from original submission to award and the number of submissions per >investigator. As a result, there has been greater burden placed on >applicants and reviewers as well as a delay in funding for meritorious >science. > >To change this trend and increase the likelihood that meritorious original >applications will be funded, the NIH will decrease the number of amendments >allowed. Accordingly, the NIH will begin to phase out second amendment >applications starting with the January 25, 2009 due date. This policy will >increase the numbers of high quality original and first amendments that can >be funded earlier. > >NIH Policy on Resubmission (Amended) Applications > >Beginning with applications intended for the January 25, 2009 due date, all >original new applications (i.e., never submitted) and competing renewal >applications will be permitted only a single amendment (A1). For this and >subsequent cohorts of original new and competing renewal applications, any >second amendment (A2) will be administratively withdrawn and not accepted >for review. Applicants who fail to receive funding after two submissions >may resubmit but only if the application is fundamentally revised to qualify >as new. A new application is expected to be substantially different in >content and scope with more significant differences than are normally >encountered in an amended application. Note that there is no time limit for >the submission of the original and subsequent A1. > >Original new and competing renewal applications that were submitted prior to >January 25, 2009 will be permitted two amendments (A1 and A2). For these >"grandfathered" applications, NIH expects that any A2 will be submitted no >later than January 7, 2011, and NIH will not accept A2 applications after >that date. > >This policy applies to all applications, including applications submitted >under the NIH Small Business Innovation Research (SBIR) and Small Business >Technology Transfer (STTR) programs, Career Development Awards, Individual >Fellowships, Institutional Training Grants, Resource Grants, Program >Projects, and Centers. Currently no amendments are permitted for >applications received in response to a Request for Applications (RFA) unless >it is specified in the Funding Opportunity Announcement, in which case only >one amendment will be permitted. ations (RFA) unless it is specified in the >Funding Opportunity Announcement, in which case only one amendment will be >permitted. > >Inquiries > >Applicants are strongly encouraged to discuss their questions with their NIH >IC contact. For additional information or questions, please contact: > >Division of Receipt and Referral >Center for Scientific Review >6701 Rockledge Drive MSC 7720 >Bethesda, MD 20892-7720 >Voice: (301) 435-0715 >Fax: (301) 480-1987 > >Or send an email to xxxxxx@mail.nih.gov. > >Clinicalmail is a service provided by the Association of American Medical >Colleges > > >====================================================================== > Instructions on how to use the RESADM-L Mailing List, including > subscription information and a web-searchable archive, are available > via our web site at http://www.hrinet.org (click on "Listserv Lists") >====================================================================== > > >====================================================================== > Instructions on how to use the RESADM-L Mailing List, including > subscription information and a web-searchable archive, are available > via our web site at http://www.hrinet.org (click on "Listserv Lists") >====================================================================== ====================================================================== Instructions on how to use the RESADM-L Mailing List, including subscription information and a web-searchable archive, are available via our web site at http://www.hrinet.org (click on "Listserv Lists") ======================================================================
